Literature DB >> 11762270

Monitoring sedation, agitation, analgesia, and delirium in critically ill adult patients.

G L Fraser1, R R Riker.   

Abstract

The recent development of valid and reliable assessment tools to monitor agitation, sedation, analgesia, and delirium in the ICU represents an essential first step in the provision of patient comfort and the development of preferred treatment strategies. To make the ICU a more humane healing environment, these assessment tools must be used as part of a comprehensive evaluation of interventional and preventive treatments, pharmacologic and nonpharmacologic. In the spirit of the JCAHO, it may be time to add the evaluation of sedation, agitation, and delirium to that of pain assessment, making all aspects of patient comfort the fifth vital sign for the critically ill.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11762270     DOI: 10.1016/s0749-0704(05)70189-5

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  9 in total

1.  Comparison and agreement between the Richmond Agitation-Sedation Scale and the Riker Sedation-Agitation Scale in evaluating patients' eligibility for delirium assessment in the ICU.

Authors:  Babar A Khan; Oscar Guzman; Noll L Campbell; Todd Walroth; Jason L Tricker; Siu L Hui; Anthony Perkins; Mohammed Zawahiri; John D Buckley; Mark O Farber; E Wesley Ely; Malaz A Boustani
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

2.  Validity and reliability of the DDS for severity of delirium in the ICU.

Authors:  Hilke Otter; Jörg Martin; Katrin Bäsell; Christian von Heymann; Ortrud Vargas Hein; Patricia Böllert; Pattariya Jänsch; Ina Behnisch; Klaus-Dieter Wernecke; Wolfgang Konertz; Stefan Loening; Jens-Uwe Blohmer; Claudia Spies
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Comparison of electrophysiologic monitors with clinical assessment of level of sedation.

Authors:  Christopher J Chisholm; Joseph Zurica; Dmitry Mironov; Robert R Sciacca; Eugene Ornstein; Eric J Heyer
Journal:  Mayo Clin Proc       Date:  2006-01       Impact factor: 7.616

Review 4.  The association between delirium and cognitive decline: a review of the empirical literature.

Authors:  James C Jackson; Sharon M Gordon; Robert P Hart; Ramona O Hopkins; E Wesley Ely
Journal:  Neuropsychol Rev       Date:  2004-06       Impact factor: 7.444

5.  Consciousness monitoring in ventilated patients: bispectral EEG monitors arousal not delirium.

Authors:  E Wesley Ely; Brenda Truman; Donna J Manzi; Jeffrey C Sigl; Ayumi Shintani; Gordon R Bernard
Journal:  Intensive Care Med       Date:  2004-05-04       Impact factor: 17.440

6.  A new two-tier strength assessment approach to the diagnosis of weakness in intensive care: an observational study.

Authors:  Selina M Parry; Sue Berney; Catherine L Granger; Danielle L Dunlop; Laura Murphy; Doa El-Ansary; René Koopman; Linda Denehy
Journal:  Crit Care       Date:  2015-02-26       Impact factor: 9.097

Review 7.  Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals.

Authors:  Julia Harris; Anne-Sylvie Ramelet; Monique van Dijk; Pavla Pokorna; Joke Wielenga; Lyvonne Tume; Dick Tibboel; Erwin Ista
Journal:  Intensive Care Med       Date:  2016-04-15       Impact factor: 17.440

8.  Early rehabilitation in critical care (eRiCC): functional electrical stimulation with cycling protocol for a randomised controlled trial.

Authors:  Selina M Parry; Sue Berney; René Koopman; Adam Bryant; Doa El-Ansary; Zudin Puthucheary; Nicholas Hart; Stephen Warrillow; Linda Denehy
Journal:  BMJ Open       Date:  2012-09-13       Impact factor: 2.692

9.  Targeted full energy and protein delivery in critically ill patients: a study protocol for a pilot randomised control trial (FEED Trial).

Authors:  Kate Fetterplace; Adam M Deane; Audrey Tierney; Lisa Beach; Laura D Knight; Thomas Rechnitzer; Adrienne Forsyth; Marina Mourtzakis; Jeffrey Presneill; Christopher MacIsaac
Journal:  Pilot Feasibility Stud       Date:  2018-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.